COVID-19 vaccines, spike proteins, and blocking the deadly virus – Monash Lens

As the global race to produce a vaccine against COVID-19 continues to heat up, researchers from the Peter Doherty Institute for Infection and Immunity and the Monash Institute for Pharmaceutical Sciences have developed two vaccine candidates that are providing encouraging results in preclinical testing.
The results have attracted almost $3 million in funding from the Commonwealth governments Medical Research Future Fund (MRFF).
The approach focuses on the golf tee-shaped protein spikes that do…

Click here to view the original article.